Difference between revisions of "Tumours of Haematopoietic and Lymphoid Tissues"

From Compendium of Cancer Genome Aberrations
Jump to navigation Jump to search
[unchecked revision][unchecked revision]
Line 30: Line 30:
 
*[[Myelodysplastic/Myeloproliferative Neoplasms (MDS/MPN), Unclassifiable|MDS/MPN, Unclassifiable]]
 
*[[Myelodysplastic/Myeloproliferative Neoplasms (MDS/MPN), Unclassifiable|MDS/MPN, Unclassifiable]]
  
==Myelodysplastic Syndromes (MDS)==
+
==Myelodysplastic Syndromes (MDS) ([[Myelodysplastic Syndromes (MDS)|Overview Page Link]])==
  
 
*[[Myelodysplastic Syndrome (MDS) with Single Lineage Dysplasia|MDS with Single Lineage Dysplasia]]
 
*[[Myelodysplastic Syndrome (MDS) with Single Lineage Dysplasia|MDS with Single Lineage Dysplasia]]
Line 105: Line 105:
 
   - [[Acute Leukemias of Ambiguous Lineage, Not Otherwise Specified (NOS)]]
 
   - [[Acute Leukemias of Ambiguous Lineage, Not Otherwise Specified (NOS)]]
  
==Precursor Lymphoid Neoplasms (B-ALL, T-ALL)==
+
==Precursor Lymphoid Neoplasms (B-ALL, T-ALL) ([[Precursor Lymphoid Neoplasms|Overview Page Link]])==
  
 
*[[B-Lymphoblastic Leukemia/Lymphoma with Recurrent Genetic Abnormalities|B-Lymphoblastic Leukemia/Lymphoma (B-ALL) with Recurrent Genetic Abnormalities]]
 
*[[B-Lymphoblastic Leukemia/Lymphoma with Recurrent Genetic Abnormalities|B-Lymphoblastic Leukemia/Lymphoma (B-ALL) with Recurrent Genetic Abnormalities]]
Line 125: Line 125:
 
   - [[NK-Lymphoblastic Leukemia/Lymphoma]]
 
   - [[NK-Lymphoblastic Leukemia/Lymphoma]]
  
==Mature B-Cell Neoplasms (CLL, Plasma Cell Neoplasms, Non-Hodgkin B-cell Lymphomas)==
+
==Mature B-Cell Neoplasms (CLL, Plasma Cell Neoplasms, Non-Hodgkin B-cell Lymphomas) ([[Mature B-Cell Neoplasms|Overview Page Link]])==
  
 
*[[Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma]]
 
*[[Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma]]
Line 235: Line 235:
 
*[[B-cell Lymphoma, Unclassifiable, with Features Intermediate Between Diffuse Large B-cell Lymphoma and Classic Hodgkin Lymphoma]]
 
*[[B-cell Lymphoma, Unclassifiable, with Features Intermediate Between Diffuse Large B-cell Lymphoma and Classic Hodgkin Lymphoma]]
  
==Mature T- and NK-cell Neoplasms==
+
==[[Mature T- and NK-cell Neoplasms]] (Overview Page Link)==
  
 
*[[T-cell Prolymphocytic Leukemia]]
 
*[[T-cell Prolymphocytic Leukemia]]
Line 297: Line 297:
 
*[[Breast Implant-Associated Anaplastic Large Cell Lymphoma]]
 
*[[Breast Implant-Associated Anaplastic Large Cell Lymphoma]]
  
==Hodgkin Lymphomas==  
+
==Hodgkin Lymphomas ([[Hodgkin Lymphomas|Overview Page Link]])==  
  
 
*[[Nodular Lymphocyte Predominant Hodgkin Lymphoma]]
 
*[[Nodular Lymphocyte Predominant Hodgkin Lymphoma]]
Line 308: Line 308:
 
   - [[Lymphocyte-Depleted Classic Hodgkin Lymphoma]]
 
   - [[Lymphocyte-Depleted Classic Hodgkin Lymphoma]]
  
==Immunodeficiency-Associated Lymphoproliferative Disorders==  
+
==Immunodeficiency-Associated Lymphoproliferative Disorders ([[Immunodeficiency-Associated Lymphoproliferative Disorders|Overview Page Link]])==  
  
 
*[[Lymphomas Associated with HIV Infection]]
 
*[[Lymphomas Associated with HIV Infection]]
Line 323: Line 323:
 
*[[Other Iatrogenic Immunodeficiency-Associated Lymphoproliferative Disorders]]
 
*[[Other Iatrogenic Immunodeficiency-Associated Lymphoproliferative Disorders]]
  
==Histiocytic and Dendritic Cell Neoplasms==  
+
==Histiocytic and Dendritic Cell Neoplasms ([[Histiocytic and Dendritic Cell Neoplasms|Overview Page Link]])==  
  
 
*[[Histiocytic Sarcoma]]
 
*[[Histiocytic Sarcoma]]

Revision as of 17:28, 3 March 2021

Myeloproliferative Neoplasms (MPN) (Overview Page Link)

Mastocytosis (Overview Page Link)

Myeloid/Lymphoid Neoplasms with Eosinophilia and Rearrangement of PDGFRA, PDGFRB or FGFR1, or with PCM1-JAK2 (Overview Page Link)

Myelodysplastic/Myeloproliferative Neoplasms (MDS/MPN) (Overview Page Link)

Myelodysplastic Syndromes (MDS) (Overview Page Link)

Myeloid Neoplasms with Germline Predisposition (Overview Page Link)

Acute Myeloid Leukemia (AML) and Related Precursor Neoplasms (Overview Page Link)

  - AML with t(8;21)(q22;q22.1); RUNX1-RUNX1T1
  - AML with with inv(16)(p13.1q22) or t(16;16)(p13.1;q22); CBFB-MYH11
  - Acute Promyelocytic Leukemia (APL) with PML-RARA
  - AML with t(9;11)(p21.3;q23.3); KMT2A-MLLT3
  - AML with t(6;9)(p23;q34.1); DEK-NUP214
  - AML with inv(3)(q21.3q26.2) or t(3;3)(q21.3;q26.2);GATA2, MECOM
  - AML Megakaryoblastic with t(1;22)(p13.3;q13.1);RBM15-MKL1
  - AML with BCR-ABL1
  - AML with Mutated NPM1
  - AML with Biallelic Mutations of CEBPA
  - AML with Mutated RUNX1
  - AML with Minimal Differentiation
  - AML without Maturation
  - AML with Maturation
  - Acute Myelomonocytic Leukemia
  - Acute Monoblastic and Monocytic Leukemia
  - Pure Erythroid Leukemia
  - Acute Megakaryoblastic Leukemia (AMKL)
  - Acute Basophilic Leukemia
  - Acute Panmyelosis with Myelofibrosis
  - Transient Abnormal Myelopoiesis (TAM) Associated with Down Syndrome
  - Myeloid Leukemia Associated with Down Syndrome

Blastic Plasmacytoid Dendritic Cell Neoplasm (Overview Page Link)

Acute Leukemias of Ambiguous Lineage (MPAL) (Overview Page Link)

  - Acute Undifferentiated Leukemia
  - Mixed Phenotype Acute Leukemia (MPAL) with t(9;22)(q34.1;q11.2); BCR-ABL1
  - Mixed Phenotype Acute Leukemia (MPAL) with t(v;11q23.3); KMT2A Rearranged
  - Mixed Phenotype Acute Leukemia (MPAL), B/Myeloid, Not Otherwise Specified
  - Mixed Phenotype Acute Leukemia (MPAL), T/Myeloid, Not Otherwise Specified
  - Mixed-Phenotype Acute Leukemia, Not Otherwise Specified (NOS), Rare Types
  - Acute Leukemias of Ambiguous Lineage, Not Otherwise Specified (NOS)

Precursor Lymphoid Neoplasms (B-ALL, T-ALL) (Overview Page Link)

  - B-ALL with t(9;22)(q34.1;q11.2); BCR-ABL1
  - B-ALL with t(v;11q23.3); KMT2A-Rearranged
  - B-ALL with t(12;21)(p13.2;q22.1); ETV6-RUNX1
  - B-ALL with Hyperdiploidy
  - B-ALL with Hypodiploidy
  - B-ALL with t(5;14)(q31.1;q32.1); IGH/IL3
  - B-ALL with t(1;19)(q23;p13.3); TCF3-PBX1
  - B-ALL, BCR-ABL1-Like
  - B-ALL with iAMP21
  - B-ALL, Not Otherwise Specified
  - Early T-Cell Precursor Lymphoblastic Leukemia
  - NK-Lymphoblastic Leukemia/Lymphoma

Mature B-Cell Neoplasms (CLL, Plasma Cell Neoplasms, Non-Hodgkin B-cell Lymphomas) (Overview Page Link)

  - Monoclonal B-cell Lymphocytosis
  - Splenic Diffuse Red Pulp Small B-cell Lymphoma
  - Hairy Cell Leukemia Variant
  - Waldenstrom Macroglobulinemia
  - Mu Heavy Chain Disease
  - Gamma Heavy Chain Disease
  - Alpha Heavy Chain Disease
  - Non-IgM Monoclonal Gammopathy of Undetermined Significance
  - Plasma Cell Myeloma
  - Plasma Cell Myeloma Variants
  - Plasmacytoma
  - Monoclonal Immunoglobulin Deposition Diseases
        - Primary Amyloidosis
        - Light Chain and Heavy Chain Deposition Disease
  - Plasma Cell Neoplasms with Associated Paraneoplastic Syndrome
        - POEMS Syndrome
        - TEMPI Syndrome
  - Paediatric Nodal Marginal Zone Lymphoma
  - Testicular Follicular Lymphoma
  - In Situ Follicular Neoplasia
  - Duodenal-Type Follicular Lymphoma
  - Leukemic Non-Nodal Mantle Cell Lymphoma
  - In Situ Mantle Cell Neoplasia
  - Fibrin-Associated Diffuse Large B-cell Lymphoma
  - Multicentric Castleman Disease
  - HHV8-Positive Diffuse Large B-cell Lymphoma, Not Otherwise Specified (NOS)
  - HHV8-Positive Germinotropic Lymphoproliferative Disorder
  - High-Grade B-cell Lymphoma with MYC and BCL2 and/or BCL6 Rearrangements
  - High-Grade B-cell Lymphoma, Not Otherwise Specified (NOS)

Mature T- and NK-cell Neoplasms (Overview Page Link)

  - Systemic EBV-Positive T-cell Lymphoma of Childhood
  - Chronic Active EBV Infection of T- and NK-cell Type, Systemic Form
  - Hydroa Vacciniforme-Like Lymphoproliferative Disorder
  - Severe Mosquito Bite Allergy
  - Enteropathy-Associated T-cell Lymphoma
  - Monomorphic Epitheliotropic Intestinal T-cell Lymphoma
  - Intestinal T-cell Lymphoma, Not Otherwise Specified (NOS)
  - Indolent T-cell Lymphoproliferative Disorder of the Gastrointestinal Tract
  - Lymphomatoid Papulosis
  - Primary Cutaneous Anaplastic Large Cell Lymphoma
  - Primary Cutaneous Gamma Delta T-cell Lymphoma
  - Primary Cutaneous CD8+ Aggressive Epidermotropic Cytotoxic T-cell Lymphoma
  - Primary Cutaneous Acral CD8+ T-cell Lymphoma
  - Primary Cutaneous CD4+ Small/Medium T-cell Lymphoproliferative Disorder
  - Angioimmunoblastic T-cell Lymphoma
  - Follicular T-cell Lymphoma
  - Nodal Peripheral T-cell Lymphoma with T Follicular Helper Phenotype

Hodgkin Lymphomas (Overview Page Link)

  - Nodular Sclerosis Classic Hodgkin Lymphoma
  - Lymphocyte-Rich Classic Hodgkin Lymphoma
  - Mixed Cellularity Classic Hodgkin Lymphoma
  - Lymphocyte-Depleted Classic Hodgkin Lymphoma

Immunodeficiency-Associated Lymphoproliferative Disorders (Overview Page Link)

  - Non-Destructive Post-Transplant Lymphoproliferative Disorders
  - Polymorphic Post-Transplant Lymphoproliferative Disorders
  - Monomorphic Post-Transplant Lymphoproliferative Disorders (B- and T/NK-cell Types)
        - Monomorphic B-cell PTLD
        - Monomorphic T/NK-cell PTLD
  - Classical Hodgkin Lymphoma Post-Transplant Lymphoproliferative Disorder

Histiocytic and Dendritic Cell Neoplasms (Overview Page Link)

  - Langerhans Cell Histiocytosis
  - Langerhans Cell Sarcoma
  - Inflammatory Pseudotumor-Like Follicular/Fibroblastic Dendritic Cell Sarcoma

Notes

*The hierarchical tumour classification structure displayed on this page is reproduced from the WHO Classification of Tumours with permission from the copyright holder, ©International Agency for Research on Cancer.